Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2000 Sep 19;97(20):10691–10696. doi: 10.1073/pnas.200318797

Microbial iron transport via a siderophore shuttle: A membrane ion transport paradigm

Alain Stintzi 1, Carmen Barnes 1, Jide Xu 1, Kenneth N Raymond 1,*
PMCID: PMC27084  PMID: 10995480

Abstract

A mechanism of ion transport across membranes is reported. Microbial transport of Fe3+ generally delivers iron, a growth-limiting nutrient, to cells via highly specific siderophore-mediated transport systems. In contrast, iron transport in the fresh water bacterium Aeromonas hydrophila is found to occur by means of an indiscriminant siderophore transport system composed of a single multifunctional receptor. It is shown that (i) the siderophore and Fe3+ enter the bacterium together, (ii) a ligand exchange step occurs in the course of the transport, and (iii) a redox process is not involved in iron exchange. To the best of our knowledge, there have been no other reports of a ligand exchange mechanism in bacterial iron transport. The ligand exchange step occurs at the cell surface and involves the exchange of iron from a ferric siderophore to an iron-free siderophore already bound to the receptor. This ligand exchange mechanism is also found in Escherichia coli and seems likely to be widely distributed among microorganisms.


The significance of iron availability to microbial growth is evinced by two dramatic examples from widely different areas of environmental and medical biology. (i) Marine phytoplankton, which lie at the base of the biomass of the oceans, usually have iron as their growth-limiting nutrient. In two large-scale experiments in the open ocean, the addition of soluble, chelated iron caused an increase in biomass of 20 orders of magnitude (1, 2). (ii) Bacterial pathogens require iron and use siderophores, low-molecular-weight chelators, to solubilize and acquire iron. An inoculum of Yersinia enterocolitica with a 50% chance of producing a lethal microbial culture in mice, administered by peritoneal injection, is reduced from 108 to only 10 cells when the injection includes the iron complex of the siderophore desferrioxamine (3). The reason for these dramatic effects is that, whereas iron is the fourth most abundant element on earth, its bioavailability is extremely limited because of its poor solubility. At physiological pH, free [Fe3+] is limited to 10−18 M, whereas virtually all living microorganisms require a minimum effective concentration of 10−8 M for growth (4). Typically, this nutritional limitation is overcome by synthesizing and excreting siderophores, which occur in four broad groups based on the chemical nature of the chelating ligands: catecholates, hydroxamates, hydroxypyridonates, or aminocarboxylates (47).

In the last 10 years, much has been learned about the mechanism of iron acquisition and transport in Gram-negative bacteria, especially Escherichia coli (811). In these bacteria, the ferric-siderophore complex must cross the outer membrane and the cytoplasmic membrane before delivering iron within the cytoplasm. The ferric complexes are too large for passive diffusion or nonspecific transport across these membranes (4); ferric-siderophore uptake is both receptor and energy dependent. Translocation of iron through the bacterial outer membrane as the ferric-siderophore requires the formation of an energy-transducing complex with the proteins TonB, ExbB, and ExbD, which couple the electrochemical gradient across the cytoplasmic membrane to a highly specific receptor and so promote transport of the iron complex across the outer membrane (4, 9, 12, 13). Once in the periplasmic space, the ferric-siderophore binds to its cognate periplasmic binding protein and is then actively transported across the cytoplasmic membrane by an ATP-transporter system. The ferric-enterobactin and ferrichrome outer membrane receptors from E. coli (FepA and FhuA, respectively) have been extensively studied (10, 11). And the crystal structures of both receptors have been solved recently (1416). These structures reveal two distinct functional domains: a 22-stranded antiparallel β-barrel, and an N-terminal globular domain, which folds inside the β-barrel, plugging the barrel pore. This structure is believed to be a common feature of any ferric-siderophore receptor and has been proposed to function like an air lock, involving two hatches (Fig. 1). The first hatch consists of the extracellular loops, which connect the strands of the barrel and fold toward the center of the pore, whereas the second hatch is formed by the N-terminal globular domain. Binding of the ferric-siderophore to its recognition site leads to closure of the external loops (first hatch) and opening of a channel in the periplasmic side of the membrane (second hatch), allowing the transit of the ferric-siderophore complex. These structural modifications are believed to be both ferric-siderophore and TonB induced (10). Indeed, a conformational change of the secondary structure of the N-terminal sequence of the protein, which switches from a helix to an unwound structure, has been observed upon binding of ferric-siderophore to FhuA and has been proposed to signal the receptor-loading status to the protein TonB (15, 16). Whether TonB induces a second conformational change (such as opening of a channel in the N-terminal globular domain) is not known, but the strict requirement of TonB in ferric-siderophore transport is undeniable. Despite this recent structural elucidation of these two receptors, the molecular basis of the mechanism of ferric-siderophore transport remains hypothetical and obscure.

Figure 1.

Figure 1

(Left) The usual siderophore iron delivery mechanism: a, ferric siderophore is bound to the protein receptor, causing a conformational change in the protein; b, the ferric siderophore is pumped through the receptor into the periplasmic space; and c, on release of the ferric siderophore, the receptor protein returns to its original conformation. (Right) The siderophore shuttle iron delivery mechanism: a, with the iron-free siderophore initially bound to the receptor protein, a second, iron-loaded siderophore binds to the receptor; b, iron exchange between the two siderophores occurs; c, this iron exchange causes a conformational change and the iron complex of the originally iron-free siderophore enters the cytoplasm; d, on release of the ferric siderophore, the receptor protein returns to its original conformation, now with the originally iron-loaded siderophore bound to the receptor protein.

The binding and transport of a ferric-siderophore to its receptor is usually highly specific, with a dissociation constant, Kd, in the range of 0.1 to 100 nM (11, 13). As an example, ferric-enterobactin binds avidly to its cognate receptor, FepA, with a Kd lower than 0.1 nM (17). Nevertheless, there is no doubt that certain receptors present lower affinity than others. For example, FhuE transports iron in E. coli via the hydroxamate siderophores coprogen, rhodotorulic acid, or ferrioxamine B (18). (Note that, whereas this receptor recognizes different siderophores, their structures are closely related and very similar at the iron coordination site.) Siderophore analogs have been used extensively to probe the role of the siderophore structure with regard to recognition by its receptor. The intensive study of ferric-enterobactin and FepA recognition (1921) showed that the catechoylamide region of the ferric-enterobactin complex is recognized by the receptor FepA.

Here, we examine, with a similar approach, the specificity of the ferric-siderophore uptake system in a fresh water bacterium, Aeromonas hydrophila. However, we find that A. hydrophila possesses a single receptor that is able to recognize and transport an extraordinarily broad range of siderophores, with chelating groups as varied as catecholate, hydroxamate or hydroxypyridonate (Fig. 2). Furthermore, this receptor utilizes an iron exchange uptake mechanism, involving exchange of iron from ferric-siderophore to an iron-free siderophore bound to the receptor (the shuttle mechanism of Fig. 1). This is a new kind of ion membrane transport mechanism and, as an iron acquisition strategy, seems likely to be quite widespread in Gram-negative bacteria.

Figure 2.

Figure 2

Structures of iron chelating functionalities and representative siderophores. (A) Catecholate group and the enterobactin, siderophore produced by E. coli; (B) hydroxypyridonate group and the TREN-1,2-HOPO, synthetic siderophore analog; (C) hydroxamate group and the desferriferrioxamine B (DFO), siderophore produced by S. pylosus.

Materials and Methods

Strains and Growth Conditions.

The strain of A. hydrophila 495A2 and the amonabactin-deficient strain SB22 were from the laboratory of Dr. R. Byers and were grown in an iron-depleted synthetic medium (glucose mineral-salt medium), at 37°C under agitation 250 rpm. The glucose mineral-salt medium is composed of (per liter): 5.0 g glucose, 1.0 g (NH4)2HPO4, 4.0 g K2HPO4, and 2.7 g KH2PO4. This growth medium was first made iron depleted by passing through a chelex100 (Bio-Rad) column, then supplemented with aqueous solutions of MgSO4 and MnSO4 to obtain a final concentration of 830 mM and 40 mM respectively, and finally filter sterilized (Millipore filters unit, pore diameter 0.22 mm).

The three strains of E. coli K-12, RW1318 (fepA entA thi proC leu trp), H1594 (fiu:Mu d1X aroB aroD139 lacU169 rpsL thiA), and HN593 (cir fiu:Mu d1X aroB aroD139 lacU169 rpsL thiA) (22), were obtained from Dr. H. Nikaido, University of California at Berkeley). E. coli strains were grown in glucose mineral-salt medium supplemented with the adequate amino acids and vitamins.

Siderophore Purification.

Amonabactin was isolated from a culture of A. hydrophila 495A2 as previously described (23). Enterobactin was purified from the growth supernatant of E. coli AN311 after a published protocol (24). Cepabactin and corynebactin were gifts from Dr. Jean-Marie Meyer (Université Louis-Pasteur, Strasbourg, France). Rhodotorulic acid, alcaligin, coprogen, and ferrichrome were isolated from bacterial growth supernatant according to published procedures (2528). Maltol was purchased from Aldrich. Syntheses of siderophore analogs, TRENCAM (29), TREN-1,2-HOPO (J.X. and K.N.R., unpublished data), deferiprone (30), and allo-maltol (31) have been described previously. Both maltol and allo-maltol were used in iron uptake experiments.

Synthesis of 55Fe Complexes of Siderophores.

Siderophore iron complexes were synthesized by mixing a solution of 55FeCl3 (NEN) and siderophore with a ratio 1:1, 2:3, or 1:3 for, respectively, a hexadentate, tetradentate or bidentate siderophore. This solution was incubated at room temperature for 2 h, and free iron was removed by precipitation after the addition of a solution of sodium phosphate 0.5 M and centrifugation at 14,000 rpm for 10 min. Radioactive 55Fe-siderophore complexes were filtered twice through membrane filters (HAWP Millipore, 0.45-mm pore size), and their concentrations were determined by monitoring the radioactivity by using a Packard scintillation counter.

Synthesis of Chromium Complexes of Siderophores.

The Cr3+ complex of deferriferrioxamine B (DFO) was synthesized as described previously (32). The Cr3+-TREN-1,2-HOPO complex was synthesized as follows: CrCl3⋅6H2O (22 mg,140 mmol) TREN-1,2-HOPO⋅HCl (105 mg, 167 mmol), and 2 equivalents of KOH (3.22 ml of a standardized 0.1037 M in methanol) were dissolved in water (20 ml). The remaining two equivalents of KOH (3.22 ml, 0.1037 M in methanol) were added dropwise with stirring, continuing for an hour at room temperature. The precipitated product was filtered or extracted into chloroform and dried in vacuo. The solid was resuspended into methylene chloride and further purified on a silica column (95:5 CH2Cl2, MeOH). A single spot was observed on silica TLC (Rf = 0.35 in 95:5 CH2Cl2, MeOH). The chromic and iron complexes had identical Rf values. FABMS+ m/z 607.2 (607.1 calculated for MH+). The 51Cr complex of desferriferrioxamine B was prepared by using Cr(II) from Zn/Hg amalgam as follows: methanol was distilled over calcium hydride, and the reaction was performed under nitrogen. Zinc metal pellets were extensively washed with dilute acid (0.1 M HCl) followed by water, then coated (mercuric nitrate in dilute nitric acid). The coated pellets were placed on a column (5 cm3) and thoroughly rinsed, first with water and subsequently with dry methanol. An acidic solution of 51CrCl3 (in 0.5 M HCl) and cold CrCl3⋅6H2O (10 mg, 63 mmol, 11.2 mCi/mmol) in methanol was added to the ZnHg column and kept there until the reduction of Cr(III) to Cr(II) was complete (the solution changed color from emerald green to light blue). The chromium solution was then added to a methanolic solution of desferriferrioxamine B (50 mg, 75.6 mmol) and anhydrous sodium acetate (75 mg, 910 mmol). The reaction was then opened to air, allowing the chromium DFO complex to reoxidize (the solution changed from red to sea green) and was then concentrated to dryness by using a stream of N2. The solid was resuspended in distilled water, applied to an XAD-2 resin (200–250 mesh), and washed thoroughly with water. The 51CrDFO complex was eluted with 50% MeOH/H2O, the methanol was evaporated, and the water was removed by lyophilization. The cold chromium complex of DFO was prepared the same way: FABMS+ m/z 610.5 (610.7 calculated for MH+). The radiolabeled 51Cr (TREN-1,2-HOPO) was prepared as described for the cold Cr (TREN-1,2-HOPO); 51CrCl3 (in 0.5 M HCl) and cold CrCl3 hexahydrate were mixed to a final concentration of (64.5 mCi/mmol).

Synthesis of 14C-LysineCAM Siderophore Analog.

The 14C labeled l-lysineCAM was prepared as follows: to a solution of 14C-l-lysine monohydrochloride (ICN, 0.05 mCi, 1.55 × 10−4 mmol) in 2% ethanol (0.5 ml), nonradioactive l-lysine (5 mg, 0.12 mmol) and ethanol (0.5 ml) were added. To the above lysine solution was added a solution of 2,3-dibenzyloxy-1-(2-mercaptothiazolide)benzamide (50 mg, 11.5 mmol) in methylene chloride (1 ml) followed by triethylamine (0.3 ml). This mixture was stirred at room temperature for 3 days. The solvent was removed under vacuo, and the residue was dissolved in methylene chloride (2 ml), extracted twice with 1 M HCl solution (1 ml), and purified by a mini flash silica gel column (1 g silica gel). The benzyl-protected 14C-labeled l-lysineCAM was obtained as a pale yellow oil, yielding 16.6 mg (78%), which was characterized by 1H and 13C NMR (500 MHz, CDCl3, 25°C). It was then deprotected by stirring with 1:1 mixture of concentrated HCl and glacial acetic acid for 3 days, the volatiles were removed under vacuo, and the residue was recrystallized from methanol/ether to give the 14C-labeled l-lysineCAM as a beige solid, yielding 8.2 mg (92%). The total radioactivity of the product was found to be higher than 0.035 mCi, and the chemical structure of the product was confirmed by 1H and 13C NMR (500 MHz, DMSO-d6, 25°C).

Siderophore Binding and Transport Experiments.

A. hydrophila was grown in an iron starvation medium as previously described (23). After 18 h, the bacteria were harvested, washed, and resuspended in the medium to an optical density at 600 nm of 0.3. Bacterial suspension (9 ml) was incubated 5 min at 37°C, and transport assays were started by addition of 55Fe-siderophore (1 ml). Aliquots of 1 ml were removed at set intervals, filtered through membrane filters (HAWP Millipore, 0.45-mm pore size), and washed with 10 ml of a cold solution of 0.1 M citrate. The filters were dried, collected in vials, and suspended in 6 ml of liquid scintillation UltimaGold XR (Packard). The vials were vigorously shaken and stored for 12 h, and the radioactivity was determined by using a Packard scintillation counter. For binding studies, bacterial suspensions, previously incubated on ice for 2 h, were supplemented with different concentrations of ferric-siderophore complexes or iron-free 14C-lysineCAM siderophore analog. After 10 min, cells were filtered, washed, and counted as described. The binding and uptake data were analyzed by using origin 6 software (34).

Results and Discussion

Amonabactin-Mediated Iron Transport in A. hydrophila.

In response to iron starvation, A. hydrophila strain 495A2 produces four bis-catecholate siderophores, collectively named amonabactins (34) (Fig. 3). These are composed of an amino acid backbone containing two lysines, one phenylalanine or tryptophane, and an optional glycine. Two 2,3-dihydroxybenzoyl groups are attached via Nɛ amide linkages to the C terminus of lysine and to the N terminus of glycine or lysine. These two catecholate groups constitute the iron-chelating functionalities of amonabactins. Their capacity to mediate Fe3+ transport in A. hydrophila 495A2 was studied by following the uptake rate of 55Fe-amonabactin for 20 min; addition of 1 mM KCN, which disrupts the cytoplasmic proton motive force, stops iron uptake (Fig. 3). No uptake was observed at 0°C or by using glucose-depleted cells (data not shown). Therefore, like other characterized siderophore-mediated iron transport systems, Fe3+ uptake in A. hydrophila is energy dependent.

Figure 3.

Figure 3

Time-dependent uptake of 55Fe-amonabactin T732 (0.4 mM) into cells of A. hydrophila and the chemical structure of amonabactin T732 and P693 (aro = indole or phenyl, respectively) and amonabactin T789 and P750 (aro = indole or phenyl, respectively). Experimental conditions were as described in Materials and Methods. (■) Uptake of 55Fe-amonabactin T732; (▴) uptake of 55Fe-amonabactin T732 in the presence of 1 mM KCN (cells were also treated 15 min with 1 mM KCN before the uptake experiment); (○) uptake of 55Fe-amonabactin T732 with a 50-fold excess of the chromic complex of DFO or TREN-1,2-HOPO, added immediately after the 4-min sample was removed (arrow).

Specificity of the Ferric-Amonabactin Uptake System.

The ability of 20 heterologous siderophores and siderophore analogs to mediate iron transport in A. hydrophila was studied by using the 55Fe-siderophore uptake assay (as described in Materials and Methods). Among the siderophores or siderophore analogs tested were maltol and allo-maltol, bis-catecholates (amonabactins), tris-catecholates (enterobactin, corynebactin and TRENCAM), mono-hydroxypyridonates (cepabactin and deferiprone), tris-hydroxypyridonate (TREN-1,2-HOPO), bis-hydroxa-mates (rhodotorulic acid and alcaligin), and tris-hydroxamates (desferriferrioxamine B, coprogen, and ferrichrome). These were all found to mediate 55Fe transport in A. hydrophila 495A2. Binding and transport characteristics of the amonabactins and three representatives of the other transported siderophores [one catecholate (enterobactin), one hydroxypyridonate (TREN-1,2-HOPO), and one hydroxamate (desferrioxamine)] are presented in Table 1. Surprisingly, unlike other siderophore transport systems, such as ferric-enterobactin uptake in E. coli, the amonabactin receptor of A. hydrophila is relatively low affinity (with a dissociation constant, Kd, more than 10-fold higher compared with ferric-enterobactin binding to its receptor FepA in E. coli), but it still transports iron at rates comparable to other ferric-siderophore uptake systems (Table 1). Enterobactin and TREN-1,2-HOPO have Kd, Kmax, and Vmax values similar to those found for the amonabactins, whereas ferrioxamine B binding is less specific, with a Kd and Kmax twice as large, suggesting a preference of iron-catecholate or catecholate-like structures as an iron source.

Table 1.

Binding and transport characteristics of ferric-amonabactin uptake system in A. hydrophila 495A2

Siderophore Binding results Kd, nM Transport results
Kmax, μM Vmax, pmol/min/OD600
Amonabactin P683 800 3.6 24
Amonabactin P750 845 2.6 22
Amonabactin T732 832 3.0 19
Amonabactin T789 903 3.2 42
Enterobactin 820 4.0 24
Ferrioxamine B 1,604 11.4 7.1
TRENCAM 1,620 6.0 4.2
TREN-1,2-HOPO 804 4.0 20

Values of the two kinetic parameters, Kmax (Michaelis constant) and Vmax (maximum rate of transport) are calculated as the mean of three independent assays and are determined from plots of 1/V vs. 1/S, where V is the uptake rate and S the ferric-siderophore concentration. Binding experiments were carried out at 0°C by using an amonabactin-deficient strain of A. hydrophila 495A2. The Kd values were determined from the concentration dependence of ferric-siderophore binding as the mean of three independent experiments. 

To investigate whether single or multiple transport systems are responsible for this iron uptake in A. hydrophila, chromium complexes of desferriferrioxamine B (DFO) and TREN-1,2-HOPO were synthesized and used as probes for inhibition of ferric siderophore transport. These Cr3+ complexes are kinetically inert but similar in structure to those of Fe3+ complexes. The uptake of each 55Fe-siderophore complex was monitored for 20 min. The Cr3+ complexes of DFO and TREN-1,2-HOPO were usually competitive inhibitors (as shown for amonabactin uptake, Fig. 3). Remarkably, the Cr3+ complexes inhibit the transport of the ferric complex of the four different amonabactins (Fig. 3), as well as cepabactin, enterobactin, corynebactin, ferrichrome, DFO, TRENCAM, TREN-1,2-HOPO, deferiprone, maltol and allo-maltol. Thus, it appears that all of these siderophores use the same transport system to mediate iron uptake. In contrast, Cr3+-DFO and Cr3+-TREN-1,2-HOPO did not inhibit the transport of the ferric complexes of coprogen, alcaligin, or rhodotorulic acid, which apparently use their own route of entry into the bacterium. We conclude that A. hydrophila possesses a single, multifunctional ferric-siderophore transport mechanism that is able to recognize and transport ferric siderophore complexes with different molecular structures and denticity, different iron-chelating functionalities (catecholate, hydroxypyridonate, and hydroxamate), different number of iron centers (one or two), and different charges.

Mechanism of Ferric-Siderophores Transport in A. hydrophila.

We consider the following possibilities for this multifunctional recognition of siderophores: (i) there is a single receptor with different recognition sites or a single receptor that recognizes a common structural feature between all of the different siderophores; (ii) there are many receptors but a common periplasmic binding protein; (iii) the ferric-siderophore delivers the iron to a surface-bound iron carrier (likely through a reduction process), with the siderophore itself remaining outside the cell, as is observed in some fungi (35) and Listeria monocytogenes (36); or (iv) there are several transport systems, but the protein TonB is present in limiting amount and is therefore unable to promote siderophore uptake. Our results show that there is a single receptor, as we now describe.

The TonB protein is essential for the transport of ferric-siderophore complexes (12, 37, 38). Therefore, if an excess of chromium DFO or chromium TREN-1,2-HOPO complex induced binding of all of the available TonB proteins to their receptors, the transport of other ferric-siderophores would be inhibited, even if they were transported by using a different receptor. However the uptake of three ferric siderophore complexes (coprogen, alcaligin, and rhodotorulic acid) were not inhibited by the addition of an excess of chromium complex. This indicates that TonB is not present in limiting quantities, ruling out possibility iv.

To further establish whether the siderophore and Fe3+ enter the bacterium together, a bis-catecholate 14C-siderophore analog, lysineCAM, was prepared. The Cr3+ complexes of DFO and TREN-1,2-HOPO inhibit the transport of Fe-lysineCAM (data not shown). Thus, lysineCAM uses the same transport system as amonabactin to mediate iron transport in A. hydrophila. The uptake rate of 55Fe and 14C from the 55Fe-14C-lysineCAM complex was monitored for 25 min. As shown in Fig. 4, 14C-siderophore is transported into the cell at the same rate as 55Fe during the first 10 min in a 3:2 ratio of 14C-siderophore/55Fe. Hence, this bis-catecholate siderophore forms a 3:2 complex with ferric ion, and both siderophore and iron are initially taken up. However, after 10 min, the transport rate of 14C-siderophore decreases, whereas that of 55Fe remains unchanged, suggesting that 55Fe is released from the siderophore inside the cell and the 14C-siderophore is excreted back into the extracellular medium. The possible role of a redox process in this ferric-siderophore transport was tested by using Ga-14C-lysineCAM (gallium has no stable divalent state and therefore cannot be reduced). The gallium complex was taken up by A. hydrophila at the same rate as the ferric complex (Fig. 4), implying that no reduction of the metal center is involved in this transport. The gallium uptake and the double labeling experiment with the 55Fe complex rule out possibility iii.

Figure 4.

Figure 4

Time-dependent uptake of 55Fe-14C-lysineCAM siderophore analog into cells of A. hydrophila. Conditions were as described in Materials and Methods except that the final complex concentration was 5 mM, cells were suspended in transport medium (30 ml) to an optical density of 1.2, and 5-ml aliquots were removed at each time and the radioactivity counted. The rate of 55Fe (■) and 14C (○) uptake were monitored simultaneously in the same assay by two-channel analysis. The rate of gallium-14C-lysineCAM (▵) uptake was monitored by following the transport of carbon 14.

The ferric metal center is the common structural feature among all of the different siderophores which are taken up by A. hydrophila. Therefore, recognition by a single receptor may imply sensing of the metal center, which can occur only through at least partial exchange between the bacterial receptor and the ferric-siderophore complex. The 51Cr complexes of DFO and TREN-1,2-HOPO, which have Kd values identical to the corresponding ferric complexes (data not shown), were found not to be transported into the cells, indicating that these complexes block the outer membrane receptor on the cell surface, which rules out possibility ii. Thus, we report a ligand exchange step in siderophore-mediated microbial iron transport.

Siderophore-Mediated Iron Transport in E. coli Through a Ligand Exchange Mechanism.

Is such a ligand exchange transport mechanism unique to A. hydrophila? To answer this question, we investigated the function of ligand exchange in siderophore-mediated iron acquisition in E. coli. The double mutant fiu cir strains did not transport 55Fe-TREN-1,2-HOPO, whereas both the fepA- and fiu-deficient strain did (data not shown). The ferric complex of TREN-1,2-HOPO mediates iron transport through the receptor Cir. The corresponding 51Cr complex of TREN-1,2-HOPO inhibits the transport of its counterpart ferric complex and was found not to be transported in E. coli K-12 strain, clearly demonstrating that a ligand exchange mechanism is also responsible for iron acquisition in E. coli, via the protein Cir. However, microbes usually have more than one uptake mechanism. For example, Ustilago sphaerogena, Streptomyces pilosus and Salmonella typhimurium take up both the ligand and metal ion of Cr3+-deferriferrichrome, Cr3+-desferriferrioxamine B, and Cr3+-deferriferrichrome, respectively. From our study, it appears that at least two different mechanisms for ferric-siderophore transport exist in these organisms: one involving ligand exchange and one which does not (Fig. 1).

Molecular Basis of the Ligand Exchange Mechanism.

Because ligand exchange is a necessary step for this new iron transport system in A. hydrophila and the receptor must sense the metal center, two mechanistic possibilities can be proposed: (i) the receptor protein contains its own iron-chelating functionality (e.g., catechol or hydroxamate groups) because of a posttranslational modification, or (ii) an iron-chelating molecule, such as a free siderophore, avidly binds to the receptor protein, accelerating ferric ion exchange between the ferric-siderophore and the free siderophore bound to the receptor and completing iron transport.

Significantly, the iron-free 14C-lysineCAM siderophore analog was found to have the same affinity for the receptor as its ferric complex, with a Kd (obtained by using whole cells of A. hydrophila) of 660 and 792 nM and a maximum capacity binding of 156 and 158 pmol/OD600 for the free and complexed siderophore, respectively. In addition, Schalk and collaborators reported the copurification of the ferric-siderophore receptor of Pseudomonas aeruginosa with its iron-free ligand (39). These findings suggested to us a mechanism of iron transport via a receptor loaded with its iron-free siderophore. Thus, we investigated whether Fe3+ in iron-loaded siderophore can be exchanged with the iron-free siderophore bound to the receptor in vivo. Bacterial cells (OD600 = 6) were incubated on ice with iron-free 14C-lysineCAM siderophore analogs (3.10−8 mol) for 5 min, corresponding to the first binding step. Unbound 14C-lysineCAM siderophores were removed by centrifugation, and the cells were washed, resuspended in uptake medium with iron-loaded siderophore (ferric amonabactin, 1.5 × 10−7 mol), and incubated at 37°C to initiate the transport (experiment A). A similar experiment, but with the omission of iron-loaded siderophores, was carried out simultaneously (experiment B). After 2 min, bacteria were harvested by centrifugation and resuspended in cold growth medium to perform a second binding step by adding iron-free 14C-lysineCAM siderophore analog (3.10−8 mol). Finally the 14C radioactivity, incorporated and bound to the cells, was monitored. The count obtained in experiment B, 5.2 × 10−10 per OD600 of 14C-lysineCAM, corresponds to the quantity of 14C-lysineCAM siderophores that bind to the cells. In experiment A, either the iron-loaded siderophore exchanges its iron with the iron-free 14C-lysineCAM siderophore bound to the receptor, allowing the transport of 14C-lysineCAM into the cells, or the iron-loaded siderophore competes for the binding site with the iron-free 14C-lysineCAM siderophore, resulting in the transport of the nonradioactive ferric siderophore. In experiment A, scintillation counting gave 10.5 × 10−10 mol of 14C-lysineCAM siderophore per 1 OD600 of cells, which corresponds to exactly double the amount of the 14C-lysineCAM siderophore able to bind to the cell surface. It is clear that the 14C-lysineCAM siderophore bound to the membrane (as a result of the first binding step) has been transported into the cells, and this occurs only if the 14C-lysineCAM has acquired iron because iron-free lysineCAM is not transported into A. hydrophila (data not shown). Thus, iron must exchange between the cold ferric-siderophore and the 14C-lysineCAM bound to the receptor. Based on these results, and in light of the crystal structures of the two receptors, FepA and FhuA, we propose the following model of ferric-siderophore transport (Fig. 5). In Fig. 5A in vivo, iron-free siderophore (in red) is in large excess over iron-loaded siderophore (in blue) and consequently predominates as bound to its cognate receptor. The crystal structures of FepA (14) and FhuA (15, 16) receptors reveal two distinct functional domains, which are believed to be a common feature of any ferric-siderophore receptor: a 22-stranded anti-parallel β-barrel and an N-terminal globular domain that folds inside the β-barrel closing the barrel pore (Fig. 5A, represented in brown). Iron-loaded siderophore is brought close enough to the iron-free bound siderophore to promote the exchange of iron (Fig. 5B, red arrow). This iron exchange is likely triggered by a pH gradient inside the barrel of the receptor, which results in the protonation of the donor and deprotonation of the acceptor. This process may be assisted by ternary complex formation involving receptor protein side chain donors. The ligand exchange induces a conformational change of the N-terminal globular domain (Fig. 5B, as represented in orange), signaling the iron-loaded status of the bound siderophore to the protein TonB (Fig. 5C). Energized TonB then triggers a conformational change of the receptor, allowing translocation of the ferric-siderophore from the cell surface to the periplasmic space. The ferric-siderophore that gave up its iron then binds to the receptor, replacing the transported ferric-siderophore complex (Fig. 5D). Finally, the receptor returns to its initial conformation. The net result is a shuttle mechanism in which siderophore ligands pass serially through a channel, with iron exchange between the siderophores a key step in the process (Fig. 1 Right). For the amonabactins, which form a 3:2 complex with ferric ion, it seems likely that the exchange of a single ligand will be enough to trigger the transport.

Figure 5.

Figure 5

Proposed model of the siderophore shuttle iron exchange mechanism for iron transport in Gram-negative bacteria. See text for a description of the steps involved in binding to the receptor, ligand exchange, and iron translocation.

Conclusions

In summary, our study of amonabactin-mediated iron transport in A. hydrophila provides an example of a ligand exchange mechanism involved in bacterial iron acquisition. The ligand exchange step occurs at the cell surface and involves the exchange of iron from a ferric siderophore to an iron-free siderophore bound to the receptor. This mechanism suggests an increase of the iron uptake rate, with increasing concentration of iron-free siderophore (characteristic of ferric-siderophore poor environment of in vivo conditions). Indeed, preliminary experimental results support this role of iron-free siderophore as a catalyst for iron uptake at very low siderophore concentrations. Because most iron transport studies (including ours) have been done under higher iron loading conditions (significantly higher than aquatic organisms are likely to experience), this behavior has not been reported earlier. The ability to select for Fe3+ via ligand exchange enables production of a single receptor with a lower affinity for its cognate siderophore but with a broad range of siderophore recognition, as observed in A. hydrophila. In a medium with a low ferric-siderophore concentration, this iron acquisition strategy is more efficient than one in which iron is acquired via a set of receptors (usually inducible), each of which is specific to a single siderophore. Furthermore, a ligand exchange mechanism for iron acquisition provides the bacterium with the ability to steal iron from exogenous siderophores. This mechanism may give A. hydrophila a great advantage in vivo, because it avoids the costly loss of secreted siderophores and provides the bacterium with the ability rapidly to acquire iron whenever it is encountered (a particular problem for aquatic or marine habitats). Whereas this is a new mechanism for siderophore-mediated iron transport in bacteria, it also represents a generally new ion transport process. This mechanism, presently found in A. hydrophila and E. coli, explains the observations from Schalk and collaborators with P. aeruginosa (39) and probably those from Hutchins and collaborators (40), who recently observed the ability of the marine bacterium, Synechococcus, to acquire iron from catecholate, hydroxamate, or mixed functional group siderophores. We suggest that this siderophore shuttle transport mechanism may be widespread in bacteria.

Acknowledgments

Ref. 23 is the previous paper in this series, “Coordination Chemistry of Microbial Iron Transport Compounds.” This research was supported by National Institutes of Health Grant AI 11744.

Abbreviation

DFO

deferriferrioxamine B

Footnotes

Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073/pnas.200318797.

Article and publication date are at www.pnas.org/cgi/doi/10.1073/pnas.200318797

References

  • 1.Frost B W. Nature (London) 1996;383:475–476. [Google Scholar]
  • 2.Coale K H, Johnson K S, Fitzwater S E, Gordon R M, Tanner S, Chavez F P, Ferioli L, Sakamoto C, Rogers P, Millero F, et al. Nature (London) 1996;383:495–501. doi: 10.1038/383495a0. [DOI] [PubMed] [Google Scholar]
  • 3.Robins-Browne R M, Prpic J K. Infect Immun. 1985;47:774–779. doi: 10.1128/iai.47.3.774-779.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Braun V, Hantke K. In: Transition Metals in Microbial Metabolism. Winkelmann G, Carrano C J, editors. Amsterdam: Harwood; 1997. pp. 81–101. [Google Scholar]
  • 5.Neilands J B. J Biol Chem. 1995;270:26723–26726. doi: 10.1074/jbc.270.45.26723. [DOI] [PubMed] [Google Scholar]
  • 6.Raymond K N, Müller G, Matzanke B F. In: Topics in Current Chemistry. Boschk F L, editor. Berlin: Springer-Verlag; 1984. pp. 50–97. [Google Scholar]
  • 7.Telford J R, Raymond K N. In: Comprehensive Supramolecular Chemistry. Atwood J L, Davies J E D, MacNicol D D, Vögtle F, editors. Vol. 1. Oxford: Elsevier Science; 1996. pp. 245–266. [Google Scholar]
  • 8.Braun V, Killmann H. Trends Biochem Sci. 1999;24:104–109. doi: 10.1016/s0968-0004(99)01359-6. [DOI] [PubMed] [Google Scholar]
  • 9.Braun V. Science. 1998;282:2202–2203. doi: 10.1126/science.282.5397.2202. [DOI] [PubMed] [Google Scholar]
  • 10.Braun V, Kantke K, Koster W. Met Ions Biol Syst. 1998;35:67–145. [PubMed] [Google Scholar]
  • 11.van der Helm D. Met Ions Biol Syst. 1998;35:355–401. [PubMed] [Google Scholar]
  • 12.Moeck G S, Coulton J W. Mol Microbiol. 1998;28:675–681. doi: 10.1046/j.1365-2958.1998.00817.x. [DOI] [PubMed] [Google Scholar]
  • 13.Postle K. Nat Struct Biol. 1999;6:3–4. doi: 10.1038/4869. [DOI] [PubMed] [Google Scholar]
  • 14.Buchanan S K, Smith B S, Venkatramani L, Xia D, Esser L, Palnitkar M, Chakraborty R, van der Helm D, Deisenhofer J. Nat Struct Biol. 1999;6:56–63. doi: 10.1038/4931. [DOI] [PubMed] [Google Scholar]
  • 15.Locher K P, Rees B, Koebnik R, Mitschler A, Moulinier L, Rosenbusch J P, Moras D. Cell. 1998;95:771–778. doi: 10.1016/s0092-8674(00)81700-6. [DOI] [PubMed] [Google Scholar]
  • 16.Ferguson A D, Hofmann E, Coulton J W, Dieterichs K, Welte W. Science. 1998;282:2215–2220. doi: 10.1126/science.282.5397.2215. [DOI] [PubMed] [Google Scholar]
  • 17.Newton S M C, Igo J D, Scott D C, Klebba P E. Mol Microbiol. 1999;32:1153–1165. doi: 10.1046/j.1365-2958.1999.01424.x. [DOI] [PubMed] [Google Scholar]
  • 18.Hantke K. Mol Gen Genet. 1983;191:301–306. doi: 10.1007/BF00334830. [DOI] [PubMed] [Google Scholar]
  • 19.Thulasiraman P, Newton S M C, Xu J, Raymond K N, Mai C, Hall A, Montague M A, Klebba P E. J Bacteriol. 1998;180:6689–6696. doi: 10.1128/jb.180.24.6689-6696.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ecker D J, Loomis L D, Cass M E, Raymond K N. J Am Chem Soc. 1988;110:2457–2464. [Google Scholar]
  • 21.Ecker D J, Matzanke B F, Raymond K N. J Bacteriol. 1986;167:666–673. doi: 10.1128/jb.167.2.666-673.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nikaido H, Rosenberg E Y. J Bacteriol. 1990;172:1361–1367. doi: 10.1128/jb.172.3.1361-1367.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Stintzi A, Raymond K N. J Biol Inorg Chem. 2000;5:57–66. doi: 10.1007/pl00010655. [DOI] [PubMed] [Google Scholar]
  • 24.Young I G, Gibson F. Methods Enzymol. 1979;56:394–398. doi: 10.1016/0076-6879(79)56037-6. [DOI] [PubMed] [Google Scholar]
  • 25.Atkin C L, Neilands J B. Biochemistry. 1968;7:3734–3739. doi: 10.1021/bi00850a054. [DOI] [PubMed] [Google Scholar]
  • 26.Moore C H, Foster L A, Gerbig D G J, Dyer D W, Gibson B W. J Bacteriol. 1995;177:1116–1118. doi: 10.1128/jb.177.4.1116-1118.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wong G B, Kappel M J, Raymond K N, Matzanke B F, Winkelmann G. J Am Chem Soc. 1983;105:810–815. [Google Scholar]
  • 28.Payne S M. Methods Enzymol. 1994;235:329–344. doi: 10.1016/0076-6879(94)35151-1. [DOI] [PubMed] [Google Scholar]
  • 29.Rodgers S J, Lee C-W, Ng C-Y, Raymond K N. Inorg Chem. 1997;26:1622–1625. [Google Scholar]
  • 30.Harris R L N. Aust. J. Chem. 1976. 1329–1334. [Google Scholar]
  • 31.Thomas A F, Marxer A. Helv Chim Acta. 1960;43:469. [Google Scholar]
  • 32.Müller G, Raymond K N. J Bacteriol. 1984;160:304–312. doi: 10.1128/jb.160.1.304-312.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Anonymous (1991–1999) origin 6 (Microcal Software, Northampton, MA).
  • 34.Telford J R, Raymond K N. J Biol Inorg Chem. 1997;2:750–761. [Google Scholar]
  • 35.Howard D H. Clin Microbiol Rev. 1999;12:394–404. doi: 10.1128/cmr.12.3.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Coulanges V, Andre P, Ziegler O, Buchheit L, Vidon D J. Infect Immun. 1997;65:2778–2785. doi: 10.1128/iai.65.7.2778-2785.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Klebba P E, Rutz J M, Liu J, Murphy C K. J Bioenerg Biomembr. 1993;25:603–611. doi: 10.1007/BF00770247. [DOI] [PubMed] [Google Scholar]
  • 38.Postle K. J Bioenerg Biomembr. 1993;25:591–601. doi: 10.1007/BF00770246. [DOI] [PubMed] [Google Scholar]
  • 39.Schalk I J, Kyslik P, Prome D, van Dorsselaer A, Poole K, Abdallah M A, Patus F. Biochemistry. 1999;38:9357–9365. doi: 10.1021/bi990421x. [DOI] [PubMed] [Google Scholar]
  • 40.Hutchins D A, Witter A E, Butler A, Luther G W. Nature (London) 1999;400:858–861. [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES